Aspen Aerogels (NYSE:ASPN) Shares Up 8.2% – Time to Buy?

Aspen Aerogels, Inc. (NYSE:ASPN)’s stock price was up 8.2% on Monday . The company traded as high as $6.68 and last traded at $6.7620. 92,454 shares traded hands during mid-day trading, a decline of 94% from the average session volume of 1,595,835 shares. The stock had previously closed at $6.25.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. Weiss Ratings reissued a “sell (d-)” rating on shares of Aspen Aerogels in a report on Wednesday, June 24th. Roth Capital restated a “buy” rating and issued a $7.75 target price on shares of Aspen Aerogels in a report on Friday. B. Riley Financial reaffirmed a “buy” rating on shares of Aspen Aerogels in a research report on Friday. Barclays increased their price target on Aspen Aerogels from $4.00 to $5.00 and gave the company an “underweight” rating in a report on Tuesday. Finally, Wall Street Zen raised shares of Aspen Aerogels from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Four research analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $5.94.

Aspen Aerogels Stock Performance

The firm has a fifty day simple moving average of $5.51 and a 200 day simple moving average of $4.47. The company has a current ratio of 2.89, a quick ratio of 2.54 and a debt-to-equity ratio of 0.32. The stock has a market cap of $508.31 million, a price-to-earnings ratio of -4.00 and a beta of 2.99.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings data on Thursday, August 6th. The construction company reported ($0.22) earnings per share for the quarter, topping the consensus estimate of ($0.23) by $0.01. The company had revenue of $49.85 million for the quarter, compared to analyst estimates of $42.42 million. Aspen Aerogels had a negative return on equity of 29.30% and a negative net margin of 62.45%.Aspen Aerogels has set its Q3 2026 guidance at -0.110–0.070 EPS. As a group, sell-side analysts expect that Aspen Aerogels, Inc. will post -0.69 earnings per share for the current year.

Institutional Investors Weigh In On Aspen Aerogels

Institutional investors and hedge funds have recently bought and sold shares of the business. Royal Bank of Canada lifted its holdings in shares of Aspen Aerogels by 95.8% during the 1st quarter. Royal Bank of Canada now owns 8,523 shares of the construction company’s stock worth $29,000 after acquiring an additional 4,169 shares during the period. Drive Wealth Management LLC acquired a new stake in Aspen Aerogels during the fourth quarter valued at approximately $30,000. Caitong International Asset Management Co. Ltd acquired a new stake in Aspen Aerogels during the fourth quarter valued at approximately $30,000. Clarus Group Inc. bought a new stake in shares of Aspen Aerogels in the 1st quarter valued at approximately $36,000. Finally, WINTON GROUP Ltd bought a new stake in shares of Aspen Aerogels in the 4th quarter valued at approximately $40,000. Institutional investors own 97.64% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.